Second European evidence-based consensus on the prevention, diagnosis and management of opportunistic infections in inflammatory bowel disease
Clicks: 31
ID: 301713
2014
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This
article has not been analysed, so there is no overall score —
reader engagement is measured and shown alongside.
Reader Engagement
Steady Performance
9.0
/100
31 views
7 readers
AI Quality Assessment
Not analyzed
Readership in this journal
SteadyRanked #6 of 18 articles by views in Journal of Crohn s and Colitis
Most read
Least read
Bar heights use a square-root scale.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
5
SUSD
one-off · no wallet required
Abstract
What makes an IBD patient immunocompromised?From genome wide association studies there is increasing evidence of an aberrant immune response in IBD. 4 Susceptibility loci involve both the innate and adaptive immune response towards a diminished diversity of commensal microbiota. 5Description of the numerous mechanisms contributing to this dysimmunity is beyond the scope of this article.Despite evidence of defective mucosal immunity, there is no proof of a systemic immune defect in patients with IBD in the absence of concomitant immunomodulator therapy.Patients with IBD are therefore rendered immunocompromised through their treatment.Immunomodulators commonly used in inflammatory bowel disease are corticosteroids, thiopurines, methotrexate, calcineurin inhibitors, anti-tumor necrosis factor agents, or other biologics.Their modes of action differ, but they all compromise to some extent the patient's immune response.To date there is no accurate biological means to quantify immunosuppression in patients with IBD.
| Reference Key |
openalex_W4293777482
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Jean‐François Rahier, Fernando Magro, Cândida Abreu, Alessandro Armuzzi, Shomron Ben‐Horin, Yehuda Chowers, Mario Cottone, Lissy de Ridder, Glen Doherty, Robert Ehehalt, María Esteve, Κωνσταντίνος Κατσάνος, Charlie W. Lees, Eithne MacMahon, Tom G. Moreels, Walter Reinisch, Herbert Tilg, Lydjie Tremblay, G. Veereman-Wauters, N. Viget, Yazdan Yazdanpanah, Rami Eliakim, Jean‐Frédéric Colombel |
| Journal | Journal of Crohn s and Colitis |
| Year | 2014 |
| DOI |
10.1016/j.crohns.2013.12.013
|
| URL | |
| Keywords | Keywords not found |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.